Rojas Cleared For NLCS Roster After Back Treatment

Miguel Rojas' postseason run continues after the Los Angeles Dodgers received encouraging news on their veteran infielder's back injury. Rojas was forced out of Game 3 of the NLDS and couldn't contribute off the bench in Game 4, but manager Dave Roberts announced that the shortstop is expected to make the NLCS roster after receiving a cortisone injection to address the issue.

The injection appears to have provided enough relief for the Dodgers to feel confident having Rojas available when they take on Milwaukee. While it's unclear whether he'll be in the lineup immediately or used as a bench option, his presence gives Los Angeles flexibility in the middle infield and at the plate heading into the Championship Series.

Why it matters. Rojas brings veteran leadership and defensive stability to a team pushing for a World Series title. His availability—even if limited—means the Dodgers won't be forced to rely entirely on backup options if they need a pinch-hitter or defensive replacement down the stretch of a best-of-seven series.

The timeline for his full recovery remains unclear, and his status could still change as the series progresses. Back injuries are notoriously unpredictable in baseball, and cortisone provides temporary relief rather than a permanent fix. How much Rojas actually plays will likely depend on pain levels and the team's needs game-to-game.

For bettors, Rojas' availability might subtly improve confidence in the Dodgers' depth, though it's unlikely to move series odds significantly unless he proves capable of returning to regular duty.

Source: original report ↗